J.P. Morgan discloses dealings in Kangji Medical privatization

On September 23, 2025, J.P. Morgan Securities PLC, an associate connected with the offeror, disclosed its dealings in Kangji Medical Holdings Limited shares. These transactions, made for its own account, occurred on September 22, 2025, and involved derivatives related to the ongoing privatization by way of scheme of arrangement.

One key transaction involved closing out a derivative contract for 499 reference securities, valued at $4,419.44, resulting in a balance of 9,879,643 shares. Additionally, J.P. Morgan issued two new derivatives: one for 12,000 reference securities, valued at $106,551.60 and maturing on September 24, 2027, increasing the resultant balance to 9,891,643 shares.

A second derivative issuance for 308,000 reference securities, valued at $2,730,120.62 and maturing on November 3, 2026, further adjusted the resultant balance to 10,199,643 shares. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.